Alpha Crest Capital Management LLC Halozyme Therapeutics, Inc. Transaction History

Alpha Crest Capital Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$38.53 - $51.78 $1.26 Million - $1.7 Million	-32,759 Reduced 74.91%	10,972 $434,000
Q2 2022 Aug 11, 2022	BUY	$37.35 - $48.3 $698,967 - $903,886	18,714 Added 74.81%	43,731 $1.92 Million
Q1 2022 May 12, 2022	SELL	$31.97 - $41.06 $446,908 - $573,977	-13,979 Reduced 35.85%	25,017 $998,000
Q4 2021 Feb 09, 2022	SELL	$31.82 - $40.75 $431,129 - $552,121	-13,549 Reduced 25.79%	38,996 $1.57 Million
Q3 2021 Nov 10, 2021	BUY	$38.47 - $46.42 $1.05 Million - $1.27 Million	27,368 Added 108.7%	52,545 $2.14 Million
Q2 2021 Aug 12, 2021	BUY	$38.84 - $51.31 $193,578 - $255,729	4,984 Added 24.68%	25,177 $1.14 Million
Q1 2021 May 13, 2021	BUY	$39.51 - $51.45 $189,687 - $247,011	4,801 Added 31.19%	20,193 $842,000
Q4 2020 Feb 12, 2021	BUY	$25.81 - $43.62 $82,514 - $139,453	3,197 Added 26.22%	15,392 $657,000
Q3 2020 Nov 12, 2020	BUY	$25.74 - $29.63 $313,899 - $361,337	12,195 New	12,195 $320,000
Q4 2019 Feb 12, 2020	SELL	$14.93 - $19.53 $389,673 - $509,733	-26,100 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$15.2 - $17.69 $115,520 - $134,444	7,600 Added 41.08%	26,100 $405,000
Q2 2019 Aug 12, 2019	SELL	$14.75 - $17.26 $501,500 - $586,840	-34,000 Reduced 64.76%	18,500 $318,000
Q1 2019 May 10, 2019	BUY	$13.94 - $17.58 $731,850 - $922,949	52,500 New	52,500 $845,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.